Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Cash from Investing Activities (2016 - 2026)

Rockwell Medical filings provide 16 years of Cash from Investing Activities readings, the most recent being -$4.1 million for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 1144.28% to -$4.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$8.5 million, a 75.59% decrease, with the full-year FY2025 number at -$8.5 million, down 75.59% from a year prior.
  • Cash from Investing Activities hit -$4.1 million in Q4 2025 for Rockwell Medical, up from -$4.3 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $9.1 million in Q1 2022 to a low of -$14.7 million in Q3 2022.
  • Median Cash from Investing Activities over the past 5 years was -$83500.0 (2023), compared with a mean of -$927000.0.
  • Biggest five-year swings in Cash from Investing Activities: surged 2782.81% in 2024 and later crashed 1144.28% in 2025.
  • Rockwell Medical's Cash from Investing Activities stood at $540000.0 in 2021, then soared by 495.93% to $3.2 million in 2022, then plummeted by 37.6% to $2.0 million in 2023, then tumbled by 116.53% to -$332000.0 in 2024, then crashed by 1144.28% to -$4.1 million in 2025.
  • The last three reported values for Cash from Investing Activities were -$4.1 million (Q4 2025), -$4.3 million (Q3 2025), and -$103000.0 (Q2 2025) per Business Quant data.